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particular, strong expression was identified in neural tis-
sues, including the neuroepithelial layer of the mesenceph-
alon, telencephalon, and neural tube of CNS and dorsal root 
ganglia. In addition, strong expression was seen in certain 
peripheral tissues including heart, intestine, muscle, and 
urinary bladder. Postnatal mice have broad spatial RHEB1 
expression in different regions of the cerebral cortex, sub-
cortical regions (including hippocampus), olfactory bulb, 
medulla oblongata, and cerebellum (particularly in Purkinje 
cells). Significant RHEB1 expression was also viewed in 
internal organs including the heart, intestine, urinary blad-
der, and muscle. Moreover, adult animals have complex tis-
sue- and organ-specific RHEB1 expression patterns with 
different intensities observed throughout postnatal develop-
ment. Its expression level is in general comparable in CNS 
and other organs of mouse. Thus, the expression pattern of 
RHEB1 suggests that it likely plays a ubiquitous role in the 
development of the early embryo with more tissue-specific 
roles in later development.
Keywords Rheb1 gene · Expression pattern · 
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Introduction
Ras homolog enriched in brain (RHEB1) is a GTPase that 
is conserved from yeast to human. RHEB1 belongs to 
a unique family within the Ras superfamily of GTPases 
(Urano et al. 2000; Li et al. 2004). Rheb1 was initially 
identified as a gene whose expression is rapidly induced 
upon synaptic activity in the rat hippocampus (Yamagata 
et al. 1994). Homologues of the Rheb gene have been 
identified in a number of non-mammalian organisms and 
Abstract Ras homolog enriched in brain (RHEB1) is a 
member within the superfamily of GTP-binding proteins 
encoded by the RAS oncogenes. RHEB1 is located at the 
crossroad of several important pathways including the 
insulin-signaling pathways and thus plays an important role 
in different physiological processes. To understand better 
the physiological relevance of RHEB1 protein, the expres-
sion pattern of RHEB1 was analyzed in both embryonic (at 
E3.5–E16.5) and adult (1-month old) mice. RHEB1 immu-
nostaining and X-gal staining were used for wild-type and 
Rheb1 gene trap mutant mice, respectively. These inde-
pendent methods revealed similar RHEB1 expression pat-
terns during both embryonic and postnatal developments. 
Ubiquitous uniform RHEB1/β-gal and/or RHEB1 expres-
sion was seen in preimplantation embryos at E3.5 and post-
implantation embryos up to E12.5. Between stages E13.5 
and E16.5, RHEB1 expression levels became complex: In 
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 mammals including mouse, rat (Yamagata et al. 1994), and 
human (Gromov et al. 1995; Mizuki et al. 1996). Lower 
eukaryotes such as yeast or Drosophila have only one gene, 
whereas mammals have two different Rheb genes Rheb1 
(originally abbreviated as Rheb) and Rheb2 (RhebL1) 
(Patel et al. 2003); for review, see (Aspuria and Tamanoi 
2004; Heard et al. 2014). Analysis of Rheb1 mRNA expres-
sion profiles showed that Rheb1 is ubiquitously expressed, 
whereas Rheb2 expression is more restricted (Saito et al. 
2005). Genetic studies in Drosophila place RHEB1 in the 
insulin-signaling pathway, downstream of the tuberous 
sclerosis complex (TSC1/TSC2) and upstream of mTOR/
S6K1 (Stocker et al. 2003). RHEB1 protein is a direct 
target of the tuberous sclerosis complex (TSC1/2), and it 
relays upstream signals to regulate mTORC1. TSC1/2 
inhibits the mTOR/S6K/4EBP1 signaling pathway by 
stimulating GTP hydrolysis of RHEB1 and its func-
tions between TSC2 and mTOR (Manning and Cantley 
2003). Inactivation of TSC1/2 leads to the activation of 
the RHEB1/mTOR/S6K signaling cascade (Uhlmann et al. 
2004). Although the molecular mechanism has not yet been 
clearly defined, RHEB-GTP activates the target of rapamy-
cin complex 1 (TORC1). TORC1 consists of multiple pro-
tein components, including the mammalian target of rapa-
mycin (mTOR) itself and the regulatory-associated protein 
of mTOR (Raptor), and is a major regulator of cell growth 
that phosphorylates multiple downstream targets including 
p70 S6 kinase (S6K) and the eukaryotic initiation factor 4E 
(eIF4E)-binding proteins 1 and 2 (4E-BP1 and 4E-BP2). 
RHEB1 activity can be blocked by rapamycin, an inhibi-
tor of mTOR. As a member of TSC1/TSC2/RHEB1/mTOR 
signaling pathway, RHEB1 participates in the regulation of 
cell growth, aging, ribosome biogenesis, protein synthesis, 
actin cytoskeletal organization, autophagy, and metabolism 
(Heard et al. 2014). The importance of the Rheb1 gene in 
tumorigenesis and other pathologies in patients and in 
mouse has become appreciated in just the last several years. 
In humans, inactivation of the TSC1–TSC2 complex leads 
to inappropriate activation of RHEB1 and results in tuber-
ous sclerosis (TS) disease (Tee et al. 2003a, b). TS is an 
autosomal dominant hamartoma syndrome caused by muta-
tions in tumor suppressor genes Tsc1/2. The hallmark of 
TS is the development of a type of benign tumors called 
hamartomas found in brain, kidney, lung, and other organs 
of TSC patients (Mizuguchi and Takashima 2001).
Overexpression and/or amplification of Rheb1 was 
detected in most breast, lung, prostate, skin, pancreatic, 
and melanoma tumor cell lines (Lu et al. 2010; Basso 
et al. 2005; Zheng et al. 2010). Also, overexpression and/
or mutations of Rheb1 were identified in tumors in differ-
ent organs of patients including prostate (Chakraborty et al. 
2008; Eom et al. 2008; Nardella et al. 2008), breast, head 
and neck (Lu et al. 2010), uterus, and kidney (Lawrence 
et al. 2014). Overexpression of RHEB1 in the tissues of 
experimental mouse models also stimulates tumor growth. 
For example, tissue-specific RHEB1 expression in basal 
epidermal keratinocytes of K14-Rheb1 transgenic mice 
leads to activation of the mTOR pathway and development 
of skin tumors (Lu et al. 2010). Moreover, increased level 
of RHEB1 can produce rapid development of aggressive 
and drug-resistant lymphomas in experimental mouse mod-
els and is highly expressed in some human lymphomas, 
resulting in activation of downstream mTOR signaling 
(Mavrakis et al. 2008). Gene targeting of Rheb1 in mouse 
leads to embryonic lethality of homozygote embryos 
around mid-gestation (Goorden et al. 2011; Zou et al. 
2011). Embryonic death most likely results from impaired 
development of the cardiovascular system (Goorden et al. 
2011; Tamai et al. 2013). Furthermore, Rheb1−/− mouse 
embryonic fibroblasts (MEFs) are much smaller than con-
trol cells and are severely impaired in their ability to prolif-
erate (Goorden et al. 2011). Conditional knockout of Rheb1 
in neural progenitor cells demonstrated that embryonic 
RHEB1 expression is essential for mTORC1 signaling and 
myelination in the brain (Zou et al. 2011). Furthermore, 
conditional Rheb1 targeting demonstrates that its expres-
sion is important for normal functions in T cells (Delgoffe 
et al. 2011), B cells (Hamada et al. 2009), and male fertility 
(Baker et al. 2014).
In summary, RHEB1 is important for the normal func-
tions of a wide array of different cells. The study of its 
expression in different tissues and organs will provide an 
opportunity to better understand its role in normal devel-
opment and perhaps help to discover novel functions and 
features.
Initially, the expression of Rheb1 and Rheb2 genes in 
human has been studied at the level of mRNA by Northern 
blot analysis (Gromov et al. 1995) and (Saito et al. 2005), 
respectively. In mouse, expression pattern of the genes 
has been studied mostly at the level of mRNA by in situ 
hybridization with particular focus on the central nervous 
system (CNS) (Yamagata et al. 1994; Magdaleno et al. 
2006), (Allen Developing Mouse Brain Atlas). It is known 
that expression level of mRNA does not always reflect pro-
tein level (Kozak 2007). The discrepancy between mRNA 
and protein levels can arise for a number of reasons, rang-
ing from stage- or tissue-specific differences in the tran-
scription, stability, or translation of mRNAs, to various 
steps in translation, or even to posttranslational events 
affecting protein stability and/or ubiquitination. With this 
potential complexity in mind, we studied the expression 
of the RHEB1 protein in wide spectrum of tissues during 
embryonic and postnatal development in wild-type mice. 
Moreover, to provide an independent approach to report 
the expression pattern, we produced and used a mutant 
Rheb1 gene trap (referred to below as Rheb1Δ/+) mouse. 
The promoter trap modification of the gene trap method 
is the tool to target genes that are active in ES cells (Frie-
drich and Soriano 1991; Skarnes et al. 1992; Wilson et al. 
1995; Fedorov 2004). The promoterless pT1βgeo gene trap 
vector (Wilson et al. 1995) containing a splice acceptor in 
front of the β-gal reporter gene and expression of the β-gal 
gene is controlled by the promoter of the “trapped gene.” 
Hence, the endogenous promoter of the trapped gene drives 
the expression of the reporter gene and thereby reflects the 
expression pattern of trapped gene. Thousands of genes 
(including Rheb1) were trapped in ES cells by EUCOMM 
to generate mutant mice; for review, see (Friedel and Sori-
ano 2010).
Materials and methods
Experimental animals
An ES clone harboring a gene trap vector pT1βgeo in 
intron 1 of Rheb1 from EUCOMM was used to gener-
ate Rheb1Δ/+ mutant mice. These ES cells (129/Sv back-
ground) were injected into (B6D2F1)xB6 blastocysts as 
described elsewhere (Fedorov et al. 1997). After germ line 
transmission (GLT), the Rheb1 targeted allele was trans-
ferred into a C57Bl/6N background (Charles River Lab; 
more than 10 backcrosses). Mutant mice were raised under 
SPF conditions. All mouse experiments were performed in 
accordance with the guidelines established by the Institu-
tional Animal Care and Use Committees of Oregon Health 
and Science University (Portland, OR, USA) and Friedrich-
Schiller-University (Jena, Germany).
PCR genotyping
Preparation of tissues from embryonic and adult mice and 
PCR were done as previously described (Tian et al. 2011). 
The presence of the pT1βgeo vector was identified with 
primers corresponding to the β-galactosidase gene: for-
ward primer 5′-GCG TTG GCA ATT TAA CCG CC-3′ and 
reverse primer 5′-CAG TTT ACC CGC TCT GCT AC-3′. 
The resulting PCR product was 450 b.p. To genotype 
wild-type Rheb1 and Rheb1Δ allele, the additional pairs of 
primers were used. The sense primer RhebF1235 5′-CCT 
AGA CTG GAC CCC TCA CA-3′ and antisense primer 
RhebR1620 5′-ACG TGA CAG TCC CCT GTT CC-3′ 
were used to amplify a 385-bp fragment of wild-type allele, 
whereas a combination of the same sense RhebF1235 
primer and mR4 5′-TGT GGG AAA GCC TTC AAA 
GGG-3′ amplifies a 238-bp fragment of the Rheb1Δ allele. 
PCR was performed using the following protocol: 95 °C for 
5 min followed by 35 cycles: 45 s at 95 °C, 45 s at 58 °C, 
and 1 min at 72 °C followed by 6-min extension at 72 °C.
Determination of sequence of trapped gene
Rapid amplification of cDNA ends (RACE) method was 
used by EUCOMM to reveal the fused transcript of the first 
exon of the Rheb1 and βgeo cassette and was confirmed 
by our laboratory. RNA was isolated from brain tissue of 
1-month Rheb1Δ/+ mouse using TRIZOL Reagent (Invit-
rogen Life Technologies, cat #15596018) according to the 
manufacturer’s instructions. RNA was reverse-transcribed 
using QuantiTect Reverse Transcription Kit (QIAGEN, 
cat #205311). The resulting cDNA was directly sequenced 
with Rheb–βGalF primer (Supplementary Table S2).
Quantitative RT‑PCR
RNA from the tissues of wild-type mice was prepared and 
reverse-transcribed as described above and treated with 
DNase. Equal amounts of input RNA were used for all 
QRT-PCRs. QRT-PCR was performed using SYBR Green 
I reagent. Primers for Ex1-Ex5 of Rheb1 (Supplemen-
tary Table S2) and transcript-specific primers for β-actin 
as an endogenous control were used to evaluate the level 
Rheb1 mRNA. The 2-ddCT relative quantification method 
was used to calculate fold difference in transcript levels 
between samples. Amplification efficiencies for the primer 
pairs were verified to be equivalent over a range of template 
concentrations. QRT-PCR was performed using an Applied 
Biosystems 7300 Real-Time PCR thermocycler (Applied 
Biosystems, Foster City, CA).
Embryo generation
Staged embryos were produced by mating between wild 
type mice or between wild-type females and Rheb1 GT 
males. The blastocysts were isolated at E3.5 from uterus, 
and zona pellucida was removed by incubating with 0.5 % 
pronase during 2-min incubation at RT. After they were 
subjected for X-gal staining or for in vitro culture 3 days 
with 5 % CO2 for 24 h at 37 °C in DMEM containing 
15 % fetal bovine serum without leukemia inhibiting fac-
tor. The E9.5–E16.5 embryos were removed from uteri and 
dissected free of extraembryonic membranes in ice-cold 
phosphate-buffered saline (PBS) and stained with X-gal 
(below). Embryo staging and organ identification were per-
formed according to Kaufman (1995).
X‑gal staining
Whole-mount specimens and cryostat-sectioned tissue sam-
ples were stained as previously described (Fedorov et al. 
2001). For whole-mount X-gal staining, Rheb1Δ/+ and 
wild-type embryos at E9.5–E13.5 were fixed for 15–90 min 
(depending on embryonic stage) in 4 % paraformaldehyde 
 at 4 °C. After fixation, embryos were washed three times 
for 5 min in PBS at RT and stained at 37 °C for 3–12 h 
(depending on stage) in a solution containing 0.04 % X-gal, 
0.01 % sodium deoxycholate, 0.02 % Nonidet P-40, 5 mM 
K3Fe(CN)6, and 5 mM K4Fe(CN)6. After staining, the spec-
imens were embedded in paraffin, and 10-μm sections were 
cut and mounted with coverslips. For X-gal staining, E16.5 
embryos and tissue samples from adult Rheb1Δ/+ mice 
were rinsed in PBS and freeze-mounted in OCT medium 
(Sakura, Japan). Frozen 25-μm sections were cut on a cry-
ostat and mounted on Super Frost Plus slides. Slides were 
stained with X-gal solution, counterstained with eosin, and 
mounted with coverslips.
Immunohistochemistry
Staged wild-type embryos were fixed overnight in Bouin’s 
solution (4 % paraformaldehyde, 0.15 % picric acid, 
pH 7.4) at 4 °C followed by paraffin embedding and cut 
on a microtome 10-μm sections. The sections were then 
blocked for endogenous peroxidase activity using 3 % 
hydrogen peroxide for 10 min prior to staining. Adult mice 
were anesthetized and transcardially perfused with physio-
logical saline (0.9 % NaCl + heparin) followed by fixation
in Bouin’s solution. The brain was then dissected, placed 
in fixative for 1 h at RT, and subsequently transferred to 
20 % sucrose in PBS for 24 h at 4 °C and freeze-mounted 
in OCT medium (Sakura, Japan). The frozen brain was 
sectioned on a cryostat, and 25-μm sections were blocked 
for endogenous peroxidase activity using 0.3 % hydrogen 
peroxide in methanol for 30 min prior to staining. The 
sections of embryonic and adult tissues were blocked for 
1 h in 5 % normal goat serum (NGS) in TBST at RT and 
then were incubated overnight in rabbit polyclonal anti-
RHEB1 primary antibody (dilution 1:400; Cell Signaling, 
# 4935) at 4 °C. Paraffin-embedded 10-µm-thick sections 
of the internal organs were deparaffined, rehydrated, and 
microwaved 6 min in 10 mM sodium citrate buffer pH 5.5. 
Subsequently, the slides were incubated 6 min in peroxi-
dase blocking solution (3 % H2O2 in PBS). After antigen 
retrieval, slides were rinsed in PBS, incubated in 20 % 
sucrose in PBS at +4 °C for 30 min, washed in PBS, and
placed in blocking buffer (2.5 % goat serum in PBS), and 
then were incubated overnight in rabbit polyclonal anti-
RHEB primary antibody (dilution 1:400; Cell Signaling, 
# 4935) at 4 °C. After incubation with primary antibody, 
the sections were incubated in biotinylated goat anti-rabbit 
secondary antibody (dilution 1:500) (Molecular Probes, 
OR, USA, cat # R-21459) for 30 min at RT in 1.5 % NGS 
in TBST. Antigen–antibody complexes were detected with 
the immunoperoxidase system (Vectastain Elite ABC Kit, 
# PK-6101, Vector Laboratories, Inc). Sections were then 
counterstained using Mayer’s hematoxylin, mounted on 
slides, and imaged under a Leica DM2000 microscope 
using LAS V3.7 software. For fluorescent immunohis-
tochemistry, the brains were isolated from the wild-type 
embryos at E15.5 and placed into 4 % paraformaldehyde 
made in PBS overnight at 4 °C. Brains were then embedded 
in 2 % agarose, and 50-μm vibratome sections were col-
lected and used for immunofluorescence staining. Before 
staining, the sections were blocked for 1 h in 0.1 % cold 
water fish-skin gelatin/1 % BSA/0.5 % TritonX-100/0.1 M 
Tris-buffered saline (all from Sigma). After blocking, pri-
mary antibodies were added (RHEB1, 1:400; Cell Signal-
ing and Nestin, 1:1000; BD Biosciences) overnight at 4 °C 
on a rotating shaker and then washed 3× in 10 min each
wash in 1× PBS. Alexa Fluor fluorescent secondary anti-
bodies (Life Technologies # R37117) were applied to the 
sections at 1:1000 in the same blocking solution as listed 
above with 5 % NGS. Sections were place on a rotating 
shaker for 1 h protected from light before being washed 
again 3× in 1× PBS as described above. Sections were
then mounted on slides and imaged using a Nikon confocal 
microscope. Identification of tissues of brain and internal 
organs of adult mice was performed using Atlas of mouse 
brain (Paxinos 2008) and histological Atlas of mouse tis-
sues (ACVP 2012).
Results
Identification of gene trap vector integration site
The promoterless pT1βgeo gene trap vector containing a 
splice acceptor in front of the β-gal reporter gene was used 
to target the Rheb1 locus (Fig. 1a, b). The precise integra-
tion site of the vector into intron 1 of Rheb1 was identi-
fied using PCR and sequencing analysis. Fifteen forward 
primers (F24–F38) were designed to cover the sequence 
of intron 1 of Rheb1 (Fig. 1c; Supplementary Table S1). 
DNA of ES clone was subjected to PCR using the forward 
primers in combination with reverse primer R4 correspond-
ing to En-2 intron region of pT1βgeo. PCR with primers 
F24 and R4 resulted in PCR product of 650 bp. Sequenc-
ing of this fragment confirmed the vector integrated 610 bp 
downstream of exon 1. The integration site is located at 
NCBIM37:5:24309691 and NCBIM37:5:24309815 of 
the mouse genome. Based on these results, the new pair 
of primers was designed and used for PCR genotyping of 
Rheb1Δ/+ mice in addition to pair of LacZ primers (Fig. 1f, 
Table S1). Fusion of the first exon of Rheb1 with the βgeo 
cassette was originally identified by EUCOMM and con-
firmed in our laboratory (Fig. 1d, e; Supplementary Table 
S1).
RHEB expression in mouse embryos
Both X-gal histochemistry and RHEB1 immunohisto-
chemistry (IHC) stainings were used to describe RHEB1 
expression pattern in mouse embryos beginning from 
embryonic day 3.5 (E3.5) through E16.5. After integra-
tion of the pT1βgeo vector, the β-gal reporter gene is con-
trolled by the promoter of Rheb1 and thereby reflects the 
pattern of expression of the trapped Rheb1 locus. Initially, 
β-gal expression was tested in ES cells, and positive X-gal 
staining was identified (Fig. 2a). Subsequently, activity was 
tested on embryos of different developmental stages after 
mating of wild-type females with Rheb1Δ/+ males. Eight of 
seventeen E3.5 embryos were X-gal positive, whereas all 
14 wild-type embryos (after breeding wild-type female and 
male) were negative (Fig. 2b). We did not perform PCR 
genotyping of embryos at this stage, but the 47 % of β-gal 
positive embryos closely reflects the expected 50 % Mende-
lian distribution, confirming that green–blue embryos were 
indeed Rheb1Δ/+ mutants. Similar results were produced in 
embryos at E6.5 cultured in vitro: 3/7- and 0/6 X-gal-posi-
tive embryos from wild-type mutant and wild-type crosses, 
respectively (Fig. 2c, d). Later, the coincidence of positive 
X-gal staining (Figs. 2e–h, 3) with genotype and Mende-
lian distribution of Rheb1Δ/+ embryos was confirmed by 
their PCR genotyping at E9.5, E12.5, and E16.5. Whole-
mount staining of embryos at E9.5 and E12.5 revealed a 
ubiquitous expression pattern (Fig. 2e–h) that is confirmed 
on histological sections (Fig. 2i, j). Thus, X-gal staining 
showed the uniform ubiquitous RHEB1 expression pattern 
on the studied stages (E3.5–E12.5 embryos). We noted a 
particularly intense expression of RHEB1 in the developing 
CNS, specifically in the neuroepithelial layer of the mid-
brain, forebrain and neural tube, and dorsal root ganglia. 
To gain data about Rheb1 expression on the second half of 
gestation, the study was extended on histological sections 
of E13.5 wild-type embryos by immunohistochemistry 
(IHC) with an anti-RHEB1 antibody. In spite of early-stage 
embryos showing uniform ubiquitous RHEB1 expression 
in CNS and other organs (Fig. 2b–i), the expression in the 
embryos in the second half of gestation became more com-
plex. Thus, the E13.5 embryos have still ubiquitous expres-
sion; however, the intensity of staining varied in different 
tissues (Fig. 2k). Differential expression is more visible on 
E16.5 Rheb1Δ/+ embryos after X-gal staining. (Figure 3a; 
Supplementary Fig. S1b).The Rheb1Δ/+ embryos at E16.5 
also revealed RHEB1/β-gal expression in different regions 
of brain. A significant level of expression was found in 
cerebral hemispheres, lens of the eye, spinal cord, and 
spinal ganglia (Fig. 3a). If intensity of staining of differ-
ent parts of CNS looks similar, then the intensity of stain-
ing of other organs varied among them. The greatest level 
of expression was found in heart (Fig. 3a, b), all regions 
of intestine (Fig. 3a, d), and urinary bladder (Fig. 3a, c). 
Fig. 1  Gene trap strategy 
used to disrupt Rheb1 locus. 
a pT1βgeo gene trap vector 
does not contain a promoter 
but contains a splice acceptor 
in front of the β-geo cassette. 
b Exon–intron structure of 
wild-type Rheb1. c Scheme of 
identification of integration site 
of pT1βgeo into intron 1 using a 
set of forward primers F24–F38 
and reverse primer R4. d Partial 
sequence of rapid amplifica-
tion of cDNA ends (RACE) 
product (5′ → 3′ orientation)
of Rheb1 gene trap ES clone 
after integration of pT1βgeo. 
Sequence of exon 1 is shown in 
bold italic font, whereas β-gal is 
shown in regular font. e Scheme 
of mRNA transcript of trapped 
allele of Rheb1. f PCR geno-
typing of founders harboring 
gene trap vector. PCR product 
(238 bp) of trapped allele is 
indicated by Δ
 Moderate expression was also observed in stomach, esoph-
agus, kidney (Fig. S1a, b, c), skeletal muscle, follicles of 
vibrissae, glans penis (Fig. 3a), with low expression in 
liver, adrenal gland (Supplementary Fig. S1a, b), pancreas, 
and testes (not shown). Faint RHEB1/β-gal expression) was 
detected in lung and liver of Rheb1Δ/+ embryos at E16.5 
(light blue hue against the pink eosin background; Fig. 3a, 
Supplementary Fig. S1a, b), whereas it is visible well in 
wild-type embryos at E13.5 after IHC (Fig. 2k). In contrast 
to Rheb1Δ/+ embryos, no β-gal expression was identified 
in wild-type embryos at any tested stage including E16.5 
(Fig. 3e and data not shown). In summary, both X-gal stain-
ing and IHC methods showed that RHEB1 protein expres-
sion changes with embryonic age from ubiquitous to differ-
ential expression patterns throughout development.
To test a possible participation of RHEB1 in regulation 
of CNS development, we conducted fluorescent immu-
nostaining of the brain of wild-type embryo at E15.5 using 
anti-RHEB and anti-Nestin antibody. Nestin is an inter-
mediate filament protein selectively expressed in neuronal 
stem cells (Sunabori et al. 2008). Fluorescent IHC showed 
co-localization of both proteins in the neuroepithelial layer 
Fig. 2  Detection of RHEB1 expression in wild-type and Rheb1Δ/+ 
mouse embryos at E3.5–E13.5. a Colonies of Rheb1Δ/+ ES cells 
expressing β-gal on the wild-type MEF. b wild-type (top) and 
Rheb1Δ/+ embryos (bottom) at E3.5 (blastocysts);. Red arrow shows 
expressing β-gal (green) in the inner cell mass (ICM). c, d In vitro 
cultured E6.5 wild-type and Rheb1Δ/+ embryos, respectively. β-gal 
activity is greater in the ICM (yellow arrows) of Rheb1Δ/+ embryo, 
than in surrounding trophoblast giant cells. β-gal activity is not found 
in wild-type embryo (d). e, f Lateral view of Rheb1Δ/+ and wild-
type embryo at E9.5, respectively; X-gal staining. g, h Lateral view 
of Rheb1Δ/+ and wild-type embryos at E12.5, respectively; X-gal 
staining. i Sagittal section of Rheb1Δ/+ embryo at E9.5. Ubiquitous 
expression (light blue) of β-gal including the neuroepithelial layer of 
midbrain, forebrain, and neural tube (red, yellow, and blue arrows, 
respectively). j Sagittal section of wild-type embryo at E9.5; hema-
toxylin–eosin staining. k Immunohistochemical detection of RHEB1 
expression in wild-type E13.5 embryo (sagittal section); blue and red 
arrows point lung and liver, respectively. Immunoperoxidase (brown) 
staining with hematoxylin counterstaining (blue). l The same embryo 
stained with hematoxylin–eosin
of embryonic brain, with projections into the cortex (Sup-
plementary Fig. S2). RHEB1 expression in neuronal stem 
cells strongly supports suggestion about its participation in 
regulation of development of CNS.
RHEB1 expression in the brain of adult mice
To describe RHEB1 expression in postnatal wild-type and 
Rheb1Δ/+mice, both IHC and X-gal stainings were used, 
respectively. Analysis of the brain of 1-month-old wild-type 
mice by IHC showed widespread expression of RHEB1 on 
different cortical regions of brain including, frontal cortex, 
motor cortex, piriform cortex, and somatosensory cortex 
(Fig. 4a, b, d, e). Similar expression patterns were visible 
in the brain of Rheb1Δ/+ mice after X-gal staining (Fig. 4c, 
f). Widespread expression was also identified in different 
subcortical brain structures, including different nuclei of 
the thalamus (Fig. 5a, b, e, f), hypothalamus, pons, medulla 
oblongata, and other regions (data not shown). Strong 
expression was also identified in hippocampal CA fields 
(Fig. 5a, b, f). Robust expression was also identified in cer-
ebellum, particularly in Purkinje cells and the cells of gran-
ular layers that become easily visible after IHC (Fig. 5c, 
g) and X-gal staining (Fig. 5d, h). Because of their large
size, the Purkinje cells of cerebellum were very useful to 
observe the intracellular localization of RHEB1 protein. 
Cytoplasmic and nuclear localization of RHEB1 is visible 
after IHC as well as X-gal staining (Fig. 5g, h). Hence, we 
show that Rheb1 is widely expressed in cerebral cortex and 
different subcortical structures of adult brain.
 RHEB1 expression in other organs of adult mice
In addition to the analysis of the RHEB1 expression in the 
brain, its expression in several other organs was exam-
ined. Because of their robust staining during embryonic 
Fig. 3  Identification of 
RHEB1/β-gal in tissues of 
Rheb1Δ/+ embryos at E16.5 
after X-gal staining (blue) coun-
terstained with eosin (red). a 
Sagittal cryosection, RHEB1/β-
gal expression in cerebral 
hemisphere (CH), lens of eye 
(L), lung (Lg), liver (Lv), spinal 
cord (SC), heart (H), intestine 
(I), urinary bladder (UB). b 
Expression in myocardial cells 
of right ventricle (cross-sec-
tioned myofibers), c in smooth 
muscle wall of urinary bladder. 
d Epithelial layer of duodenum. 
e Abdominal cavity of wild-type 
embryo at E16.5 after X-gal 
staining; sagittal cryosection
 development (Fig. 3), we analyzed RHEB1 expression in 
heart, intestine, urinary bladder, and muscle of adult animals. 
As shown in Fig. 6a–h, RHEB1 expression remains as intense 
as in the E16.5 embryo. To compare approximately the level 
of Rheb1 transcription in CNS and different organs of adult 
mice, the level of Rheb1 mRNA was evaluated by QRT-PCR 
Fig. 4  Detection of RHEB1 expression in the cortex of brain of 
1-month-old wild-type and Rheb1Δ/+ mice; sagittal sections. a, b, d, 
e RHEB1 expression on different cortical regions of wild-type brain. 
c, f RHEB1/β-gal expression in the brain of Rheb1Δ/+ mouse. Frontal 
cortex (FC), motor cortex (MC), piriform cortex (PC), somatosensory 
cortex (SSC)
Fig. 5  Detection of RHEB1 expression in the different regions of the 
brain of 1-month-old wild-type and Rheb1Δ/+ mice. a, b, e, f RHEB1 
expression in different regions on sagittal section of wild-type brain: 
dentate gyrus (DG), dorsal lateral geniculate nucleus (DLG) of the 
thalamus, hippocampus (H). c, g and d, h RHEB1 expression in cer-
ebellum, of wild-type and Rheb1Δ/+ mice, respectively; simple lobule 
(SL) and ansiform lobule (AF) of cerebellum. g, h Strong expres-
sion of RHEB1 or RHEB1/β-gal in the nuclei of Purkinje cells (black 
arrows) and in the cells of the granular layer (red arrows) is observed
in several regions of brain and internal organs (kidney and 
heart) of WT mouse (Fig. S3). Similar high expression was 
identified in temporal cortex of the brain and heart, whereas 
other tissue/organs have twofold to threefold less expression. 
Thus, adult animals have broad spatial expression patterns 
with different intensity throughout postnatal development.
Discussion
In prior work, the systematic analysis of Rheb1 expression 
was performed in mice at age E9.5 to postnatal day 56 (p. 
56), specifically focusing on the level of mRNA in the CNS 
(Allen Developing Mouse Brain Atlas) and (Magdaleno 
et al. 2006). In the present study, we examined the expres-
sion of RHEB1 protein in a wide spectrum of mouse tissues 
from both preimplantation (E3.5) and postimplantation 
embryonic stages as well as from adult mice. Moreover, 
we used wild-type and Rheb1Δ/+ mice that allowed us to 
use two independent methods for assessing RHEB1 expres-
sion. In general, RHEB1 IHC and X-gal staining demon-
strated similar expression patterns during both embry-
onic and postnatal development. We found that RHEB1 is 
actively expressed in preimplantation embryos at E3.5 and 
Fig. 6  Immunohistochemical 
detection of RHEB1 expres-
sion on cryosections of the 
tissues of 4-week-old wild-type 
and Rheb1Δ/+ mice. a RHEB1 
expression in longitudinally ori-
ented cardiomyofibers of heart, 
c in the myocytes of striated 
muscle, e in epithelium cells 
of villi of ileum (intestine). b, 
d, f Corresponding no primary 
antibody control. Immunop-
eroxidase (brown) staining; in 
addition, sections were counter-
stained with hematoxylin (blue). 
g, h RHEB1/β-gal expression in 
smooth muscle of urinary blad-
der of Rheb1Δ/+ mouse after 
X-gal staining
perhaps earlier. It seems that although RHEB1 is actively 
expressed in preimplantation stages, its deficiency does not 
affect preimplantation development but is critical soon after 
implantation in the period of organogenesis, and Rheb1 
−/− embryos die on mid-gestation (Goorden et al. 2011; 
Zou et al. 2011). Moreover, we observed that embryos 
at the age E3.5–E12.5 have uniform ubiquitous RHEB1 
expression, whereas in E13.5 and E16.5 embryos and later 
in adult mice, the expression shifts from uniform ubiqui-
tous to a more complex, tissue-specific pattern. Different 
level of expression is more prominent on the section of 
Rheb1Δ/+ E16.5 embryos (Fig. 3; Supplementary Fig. S1). 
Although IHC and X-gal staining showed similar expres-
sion patterns for wild-type RHEB1 and targeted RHEB1/β-
gal proteins, there were staining differences among some 
organs like in embryonic lung and liver at E13.5 and E16.5. 
Our gene trap vector pT1βgeo contains neo gene, and its 
expression might slightly reduce RHEB1/β-gal expression 
in these organs. Based on these observations, we cannot 
conclude that RHEB1 expression disappeared completely 
in some organs/tissues. More likely, it is gradual reduction 
in the expression in some tissues during embryonic devel-
opment after E12.5, and therefore, in some cases, we can-
not see low level of expression on histological section at 
later stages. To conclude complete absence of expression 
would require laser capture of individual cells with quanti-
fication via QRT-PCR.
RHEB1 protein expression pattern in the brain of wild-
type and Rheb1Δ/+ embryos and adult mice was similar to 
Rheb1 mRNA expression pattern of wild type published 
previously (Allen Developing Mouse Brain Atlas) and 
(Magdaleno et al. 2006). Interestingly, we identified the 
high level of RHEB1 protein not only in different regions 
of the brain but also in several internal organs such as heart, 
intestine, and urinary bladder of embryos and adult ani-
mals. The comparison of RHEB1 expression levels in inter-
nal organs versus brain by QRT-PCR showed that the levels 
are comparable in general. The strong RHEB1 synthesis in 
the internal organs might also infer the functional signifi-
cance of RHEB1 in these organs, and abnormalities in the 
regulation of RHEB1 in these tissues can initiate pathologi-
cal changes including cancer.
The goal of our study was to analyze the overall expres-
sion pattern of RHEB1 protein in different tissues of 
mouse. Although our primary goal was not to focus on the 
details of intracellular localization of RHEB1, we never-
theless observed RHEB1 localization in some cells. The 
localization RHEB1 in cytoplasm is visible in the cells of 
brain and internal organs of wild-type mice after IHC as 
well as in the cells of Rheb1Δ/+ mice after X-gal staining. 
Analysis of nuclear staining is more complicated. In most 
tissues, it is difficult to conclude that we detected RHEB1 
nuclear localization in general even though it looks like 
nuclear staining. Some cells are small like the cells of the 
cerebellar molecular layer. In other cases, it is not possible 
to discriminate details of X-gal staining between subcellu-
lar nuclear compartments or perinuclear regions such as the 
Golgi apparatus or endoplasmic reticulum. The question 
will be answered after immunofluorescent staining via con-
focal microscopy in future studies. However, Purkinje cells 
of the cerebellum are sufficiently large to permit detection 
of the intracellular localization of RHEB1 protein. In these 
cells, the cytoplasmic and nuclear localization of RHEB1 is 
clearly visible after IHC as well as X-gal staining. To per-
form intracellular signaling from plasma membrane inside 
cells, the proteins of Ras family have a C-terminal CAAX 
(C = cysteine, A = aliphatic, X = terminal amino acid)
motif which is responsible for the association with plasma 
and endo membranes; for review, see (Schmick et al. 2015). 
In contrast to other proteins of RAS superfamily, endoge-
nous RHEB1 has an atypical CAAX motif (CSVM) (Aspu-
ria and Tamanoi 2004). The identification of RHEB1 in 
cell compartments demonstrated in general localization to 
the Golgi apparatus, endoplasmic reticulum (Buerger et al. 
2006; Jiang and Vogt 2008; Hanker et al. 2010), vesicular 
structures (Saito et al. 2005; Buerger et al. 2006; Sancak 
et al. 2008), and mitochondria (Ma et al. 2008). Our sur-
prising observation of RHEB1 localization in the nuclei of 
the Purkinje cells of cerebellum is supported by fact that 
other members of TSC1/2/RHEB1/mTOR signaling path-
way including tuberin, an upstream regulator of RHEB1 
and mTOR target of RHEB1, are also localized in the cyto-
plasm and nucleus of cells (Rosner et al. 2007). Moreover, 
by using multiphoton microscopy, EGFP-RHEB1 localiza-
tion was recently detected in both cytoplasmic and nuclear 
regions in living HEK293, HeLa, and SHO transiently 
transfected cells (Yadav et al. 2013). The level of RHEB1 
expression was evaluated as ~40 % within the cell nucleus 
and ~60 % within the cytoplasm, the Golgi apparatus, and 
ER together.
We identified nuclear localization of RHEB1 in Purkinje 
cells by both IHC and X-gal staining.
To enter into the nucleus, the nuclear proteins penetrate 
the nuclear membrane through the nuclear pore complex 
(NPC) (Davis 1995) or through nuclear import pathways 
(Sorokin et al. 2007). Nuclear import depends on inter-
action between the nuclear localization signal (NLS) of 
nuclear protein and its import receptor. NLS is a polyba-
sic sequence comprised of multiple lysines (K) or arginines 
(R). Lin et al. (2014) showed that template PxxK[KR]
x[KR]xx (a very common NLS motif) may have many 
modifications and depended on binding affinity to its 
import receptor, and it can potentially have different nuclear 
import activity. Exon 1 of Rheb1 presents in both wild-type 
Rheb1 and mutant Rheb1/β-gal gene of our experimental 
mice. After translation of Exon 1, the N-terminus of both 
proteins (wild-type RHEB1 and targeted RHEB1/β-gal) 
contain PQSKSRK amino acid sequence that is similar to 
PxxK[KR]x[KR]. We suggest that PQSKSRK motif func-
tions as a NLS to import RHEB1 into nuclei. The role and 
precise localization of RHEB1 within the cell nucleus is 
unclear and must be studied in more detail in the future. 
Finally, we extended here our knowledge about RHEB1 
expression on the protein level during embryogenesis and 
postnatal development in the CNS and several internal 
organs. Our studies will thus contribute to further elucidat-
ing the function of RHEB1 in its normal biological context 
as well as its role in the pathogenesis of different diseases.
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